SALT LAKE CITY–(BUSINESS WIRE)–USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended October 3, 2026. Key Financial Results Third Quarter 2026 vs. Third Quarter 2025 Net sales of $206 million versus $214 million. Net loss of $(5.6) million versus $(6.5) million. Diluted EPS of $(0.30) as compared with $(0.36). Adjusted diluted EPS(1) of $(0.11) as compared with $(0.15). Adjusted EBITDA(2) of $12.1 million versus $13.8 million. Core Nutri
